Unibest
← Back to patent-cliff list

Zuranolone

Tier C — Watch / trade

Zuranolone

Sage Therapeutics Inc
Originator
2023
First approval
-
Expiry (public)
$0.2B ▲
Peak sales
Small molecule
Type

Targets:GABAAR

Brand:Zurzuvae

Indications (approved):产后抑郁症, Depressive disorder

Regional status

US
Approved
2023-08-04
EU
Approved
2025-09-17
China
-
Japan
Approved
2025-12-22

Synthetic routes & intermediates1 routes

Originator routes × 1Optimised (non-patent) × 0Process routes × 0

Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.

OriginatorRoute 1Steps 7 · Total yield 9 mg
SAGE-217-001734-32-7SAGE-217-0025696-51-5SAGE-217-0031632051-92-3SAGE-217-0041430063-91-4SAGE-217-0051430063-92-5SAGE-217-006162882-77-1SAGE-217-0071430063-93-6SAGE-217-00831108-57-3API · Zuranolone
CodeCAS No.Intermediate
SAGE-217-001734-32-7Available(8R,9S,10R,13S,14S)-13-methyl-1,6,7,8,9,10,11,12,13,14,15,16-dodecahydro-3H-cyclopenta[a]phenanthrene-3,17(2H)-dione
SAGE-217-0025696-51-5Available(5R,8R,9R,10S,13S,14S)-13-methyltetradecahydro-3H-cyclopenta[a]phenanthrene-3,17(2H)-dione
SAGE-217-0031632051-92-3Available(3R,5R,8R,9R,10S,13S,14S)-3-hydroxy-3,13-dimethylhexadecahydro-17H-cyclopenta[a]phenanthren-17-one
SAGE-217-0041430063-91-4Available(3R,5R,8R,9R,10S,13S,14S,Z)-17-ethylidene-3,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-3-ol
SAGE-217-0051430063-92-5Available(3R,5R,8R,9R,10S,13S,14S,17S)-17-(1-hydroxyethyl)-3,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-3-ol
SAGE-217-006162882-77-1Available1-((3R,5R,8R,9R,10S,13S,14S,17S)-3-hydroxy-3,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)ethan-1-one
SAGE-217-0071430063-93-6Available2-bromo-1-((3R,5R,8R,9R,10S,13S,14S,17S)-3-hydroxy-3,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)ethan-1-one
SAGE-217-00831108-57-3Available1H-pyrazole-4-carbonitrile

Frequently asked questions

What are the approved indications of Zuranolone?

Approved indications include: 产后抑郁症, Depressive disorder.

When does the Zuranolone patent expire?

No public expiry year is available for Zuranolone yet; this page updates once verified.

How many synthesis routes are recorded for Zuranolone?

1 synthesis routes are recorded; the shortest is 7 steps with 9 mg total yield. Intermediates in each route carry codes and CAS numbers.

Where can I buy Zuranolone intermediates?

8 intermediate CAS of Zuranolone are available through the Unibest supply network — see the route tables on this page and request a quote per CAS.

How do I get a quote for Zuranolone intermediates?

Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.

Source: cross-verified data (structured fields only) · 2026-09-29